Safety and efficacy of fingolimod in patients with multiple sclerosis in real world setting
Phase of Trial: Phase IV
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Fingolimod (Primary) ; Natalizumab
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms VIRGILE
- 02 Nov 2016 Results from one year data analysis (n=1011), presented at the 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
- 24 Feb 2016 Planned number of patients changed from 1200 to 1800.
- 23 Feb 2016 New trial record